Differential COX-2 induction by viral and bacterial PAMPs: Consequences for cytokine and interferon responses and implications for anti-viral COX-2 directed therapies

作者: Nicholas S. Kirkby , Anne K. Zaiss , William R. Wright , Jing Jiao , Melissa V. Chan

DOI: 10.1016/J.BBRC.2013.07.006

关键词:

摘要: Cyclooxygenase 2 (COX)-2 is induced by bacterial and viral infections has complex, poorly understood roles in anti-pathogen immunity. Here, we use a knock-in luciferase reporter model to image Cox2 expression across range of tissues mice following treatment with the either prototypical pathogen-associated molecular pattern (PAMP), LPS, which activates Toll-like receptor (TLR)4, or poly(I:C), PAMP, TLR3. LPS all examined. In contrast, poly(I:C) elicited milder response, limited subset tissues. A panel cytokines interferons was measured plasma wild-type, Cox1−/− Cox2−/− treated MALP2 (TLR2/6), Pam3CSK4 (TLR2/1), R-848 (TLR7/8) CpG ODN (TLR9), establish whether/how each COX isoform modulates specific PAMP/TLR responses. Only notable loss condition (inactivity, hunching, piloerection). However, TLR agonists produced cytokine responses, many were modulated fashions Cox1 gene deletion. Notably observed opposing effects deletion on responses consistent differing abilities PAMPs induce expression. IL-1β interferon-γ hypothermia LPS. response exhibited enhanced interferon (IFNα,β,γ,λ) related (IP-10, IL-12). These observations suggest that COX-2 selective inhibitor, given early infection, may enhance and/or prolong endogenous thereby increase anti-viral

参考文章(24)
D.A. Kujubu, B.S. Fletcher, B.C. Varnum, R.W. Lim, H.R. Herschman, TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue Journal of Biological Chemistry. ,vol. 266, pp. 12866- 12872 ,(1991) , 10.1016/S0021-9258(18)98774-0
Joann Y. Richardson, Martin G. Ottolini, Lioubov Pletneva, Marina Boukhvalova, Shuling Zhang, Stefanie N. Vogel, Gregory A. Prince, Jorge C. G. Blanco, Respiratory Syncytial Virus (RSV) Infection Induces Cyclooxygenase 2: A Potential Target for RSV Therapy The Journal of Immunology. ,vol. 174, pp. 4356- 4364 ,(2005) , 10.4049/JIMMUNOL.174.7.4356
Rongbin Zhou, Haiming Wei, Rui Sun, Zhigang Tian, Recognition of Double-Stranded RNA by TLR3 Induces Severe Small Intestinal Injury in Mice Journal of Immunology. ,vol. 178, pp. 4548- 4556 ,(2007) , 10.4049/JIMMUNOL.178.7.4548
Tomasz A. Swierkosz, Jane A. Mitchell, Timothy D. Warner, Regina M. Botting, John R. Vane, Co-induction of nitric oxide synthase and cyclo-oxygenase: interactions between nitric oxide and prostanoids. British Journal of Pharmacology. ,vol. 114, pp. 1335- 1342 ,(1995) , 10.1111/J.1476-5381.1995.TB13353.X
Nicholas S Kirkby, Martina H Lundberg, Louise S Harrington, Philip DM Leadbeater, Ginger L Milne, Claire MF Potter, Malak Al-Yamani, Oladipupo Adeyemi, Timothy D Warner, Jane A Mitchell, None, Cyclooxygenase-1, not cyclooxygenase-2, is responsible for physiological production of prostacyclin in the cardiovascular system. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 109, pp. 17597- 17602 ,(2012) , 10.1073/PNAS.1209192109
Pietro Andreone, Carmela Cursaro, Annagiulia Gramenzi, Andrea Buzzi, Rita Miniero, Giuseppe Sprovieri, Giovanni Gasbarrini, Indomethacin enhances serum 2′5′-oligoadenylate synthetase in patients with hepatitis B and C virus chronic active hepatitis Journal of Hepatology. ,vol. 21, pp. 984- 988 ,(1994) , 10.1016/S0168-8278(05)80606-3
Jules I Schwartz, Chi‐Chung Chan, Saurabh Mukhopadhyay, Kathleen J McBride, Terry M Jones, Sherilyn Adcock, Carl Moritz, Jerris Hedges, Kenneth Grasing, David Dobratz, Robert A Cohen, Michael H Davidson, Kenneth A Bachmann, Barry J Gertz, Cyclooxygenase-2 inhibition by rofecoxib reverses naturally occurring fever in humans Clinical Pharmacology & Therapeutics. ,vol. 65, pp. 653- 660 ,(1999) , 10.1016/S0009-9236(99)90087-5
Kuniaki Ejima, Matthew D. Layne, Irvith M. Carvajal, Patricia A. Kritek, Rebecca M. Baron, Yen-Hsu Chen, Jeffrey Vom Saal, Bruce D. Levy, Shaw-Fang Yet, Mark A. Perrella, Cyclooxygenase‐2 deficient mice are resistant to endotoxin‐induced inflammation and death The FASEB Journal. ,vol. 17, pp. 1325- 1327 ,(2003) , 10.1096/FJ.02-1078FJE